Comparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine

JAMA Netw Open. 2021 Sep 1;4(9):e2124331. doi: 10.1001/jamanetworkopen.2021.24331.

Abstract

This cohort study compares antibody responses in a cohort in which both BNT162b2 and mRNA-1273 COVID-19 vaccines were administered.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • 2019-nCoV Vaccine mRNA-1273
  • Adult
  • Age Factors
  • Antibody Formation*
  • BNT162 Vaccine
  • COVID-19 / immunology*
  • COVID-19 Vaccines / immunology*
  • Female
  • Humans
  • Immunoglobulin G / blood
  • Immunoglobulin G / immunology
  • Male
  • Middle Aged
  • SARS-CoV-2 / immunology
  • Spike Glycoprotein, Coronavirus / blood
  • Spike Glycoprotein, Coronavirus / immunology

Substances

  • COVID-19 Vaccines
  • Immunoglobulin G
  • Spike Glycoprotein, Coronavirus
  • 2019-nCoV Vaccine mRNA-1273
  • BNT162 Vaccine